N-terminal Glutamate to Pyroglutamate Conversionin Vivofor Human IgG2 Antibodies

Naturally occurring glycan forms of human immunoglobulins G1 and G2

(2010) Gregory C. Flynn et al.   MOLECULAR IMMUNOLOGY

To protect peptide pharmaceuticals against peptidases

(2010) R. Rink et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule

(2009) D. Ouellette et al.   ANALYTICAL BIOCHEMISTRY

Human antibody Fc deamidation in vivo

(2009) Y. Diana Liu et al.   BIOLOGICALS

Quality by design for biopharmaceuticals

(2009) Anurag S Rathore et al.   NATURE BIOTECHNOLOGY

Roadmap for implementation of quality by design (QbD) for biotechnology products

(2009) Anurag S. Rathore   TRENDS IN BIOTECHNOLOGY

Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution

(2008) Stephan Schilling et al.   BIOLOGICAL CHEMISTRY

Human IgG2 Antibody Disulfide Rearrangementin Vivo

(2008) Y. Diana Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY